糖代谢紊乱与脑卒中的关系研究进展

摘要/Abstract

中图分类号:

R743.3

高鹤, 江思瑜, 郭晓玲, 周博, 王新. 糖代谢紊乱与脑卒中的关系研究进展[J]. 承德医学院学报, 2022, 39(6): 505-510.

[1] Fuentes B, Ortega-Casarrubios MA, Sanjosé B, et al.Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: how well are we correcting it?: implications for outcome[J]. Stroke, 2010, 41(10): 2362-2365.
[2] Lee AK, Warren B, Lee CJ,et al.The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes[J]. Diabetes Care, 2018, 41(1): 104-111.
[3] Liao HW, Saver J, Yeh HC,et al.Low fasting glucose and future risks of major adverse outcomes in people without baseline diabetes or cardiovascular disease: a systematic review and meta-analysis[J]. BMJ Open, 2019, 9(7): e026010.
[4] Zhu B, Pan Y, Jing J, et al.Stress Hyperglycemia and Outcome of Non-diabetic Patients After Acute Ischemic Stroke[J]. Front Neurol, 2019, 10: 1003.
[5] Chen X, Liu Z, Miao J, et al.High Stress Hyperglycemia Ratio Predicts Poor Outcome after Mechanical Thrombectomy for Ischemic Stroke[J]. J Stroke Cerebrovasc Dis, 2019, 28(6): 1668-1673.
[6] Xing L, Liu S, Tian Y, et al.C-R Relationship between Fasting Plasma Glucose and Unfavorable Outcomes in Patients of Ischemic Stroke withoutDiabetes[J]. J Stroke Cerebrovasc Dis, 2019, 28(5): 1400-1408.
[7] Zhang F, Zhang S, Tao C, et al.Association between serum glucose level and spot sign in intracerebral hemorrhage[J]. Medicine (Baltimore), 2019, 98(11): e14748.
[8] Gofir A, Mulyono B, Sutarni S.Hyperglycemia as a prognosis predictor of length of stay and functional outcomes in patients with acute ischemic stroke[J]. Int J Neurosci, 2017, 127(10): 923-929.
[9] Skafida A, Mitrakou A, Georgiopoulos G,et al.In-hospital dynamics of glucose, blood pressure and temperature predict outcome in patients with acute ischaemic stroke[J]. Eur Stroke J, 2018, 3(2): 174-184.
[10] Osei E, Fonville S, Zandbergen AAM, et al.Impaired fasting glucose is associated with unfavorable outcome in ischemic stroke patients treated with intravenous alteplase[J]. J Neurol, 2018, 265(6): 1426-1431.
[11] Cai Y, Wang C, Di W, et al.Correlation between blood glucose variability and the risk of death in patients with severe acute stroke[J]. Rev Neurol(Paris), 2020, 176(7-8): 582-586.
[12] Hui J, Zhang J, Mao X, et al.The initial glycemic variability is associated with early neurological deterioration in diabetic patients with acute ischemic stroke[J]. Neurol Sci, 2018, 39(9): 1571-1577.
[13] Pan Y, Jing J, Wang Y, et al.Association of hemoglobin glycation index with outcomes of acute ischemic stroke in type 2 diabetic patients[J]. Neurol Res, 2018, 40(7): 573-580.
[14] Yang Chih-Jen, Liao Wen-I, Wang Jen-Chun, et al.Usefulness of glycated hemoglobin A1c-based adjusted glycemic variables in diabetic patients presenting with acute ischemic stroke[J]. Am J Emerg Med, 2017, 35(9): 1240-1246.
[15] Roquer J, Giralt-Steinhauer E, Cerdà G, et al.Glycated Hemoglobin Value Combined with Initial Glucose Levels for Evaluating Mortality Risk in Patients with Ischemic Stroke[J]. Cerebrovasc Dis, 2015, 40(5-6): 244-250.
[16] Mitsios JP, Ekinci EI, Mitsios GP, et al.Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta-Analysis[J]. J Am Heart Assoc, 2018, 7(11): e007758.
[17] Wang H, Cheng Y, Chen S, et al.Impact of Elevated Hemoglobin A1c Levels on Functional Outcome in Patients with Acute Ischemic Stroke[J]. J Stroke Cerebrovasc Dis, 2019, 28(2): 470-476.
[18] Lattanzi S, Bartolini M, Provinciali L, et al.Glycosylated Hemoglobin and Functional Outcome after Acute Ischemic Stroke[J]. J Stroke Cerebrovasc Dis, 2016, 25(7): 1786-1791.
[19] Zhang G, He M, Xu Y, et al.Hemoglobin A1c predicts hemorrhagic transformation and poor outcomes after acute anterior stroke[J]. Eur J Neurol, 2018, 25(12): 1432-e122.
[20] Abe A, Sakamoto Y, Nishiyama Y, et al.Decline in Hemoglobin during Hospitalization May Be Associated with Poor Outcome in Acute Stroke Patients[J]. J Stroke Cerebrovasc Dis, 2018, 27(6): 1646-1652.
[21] Pan Y, Jing J, Wang Y, et al.Association of hemoglobin glycation index with outcomes of acute ischemic stroke in type 2 diabetic patients[J]. Neurol Res, 2018,40(7): 573-580.
[22] Mukai N, Ninomiya T, Hata J, et al.Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study[J]. Cardiovasc Diabetol, 2015,14: 84.
[23] Ma Xi, Shen Y, Hu X, et al.Associations of glycated haemoglobin A1c and glycated albumin with subclinical atherosclerosis in middle-aged and elderly Chinese population with impaired glucose regulation[J]. Clin Exp Pharmacol Physiol, 2015, 42(6): 582-587.
[24] 冯小萌,纪蒙,王广. 糖化白蛋白对老年糖尿病患者再发脑梗死的影响[J]. 中国医师进修杂志,2016,39(5):440-443.
[25] Li J, Wang Y, Wang D, et al.Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke[J]. Neurology, 2015, 84(13): 1330-1336.
[26] Saliba W, Barnett-Griness O, Gronich N, et al.Association of Diabetes and Glycated Hemoglobin With the Risk of Intracerebral Hemorrhage: A Population-Based Cohort Study[J]. Diabetes Care, 2019, 42(4): 682-688.
[27] Hui J, Zhang J, Mao X, et al.The initial glycemic variability is associated with early neurological deterioration in diabetic patients with acute ischemic stroke[J]. Neurol Sci, 2018, 39(9): 1571-1577.
[28] Jin C, Li G, Rexrode KM,et al.Prospective Study of Fasting Blood Glucose and Intracerebral Hemorrhagic Risk[J]. Stroke, 2018, 49(1): 27-33.
[29] Fahim VF, Wadie W, Shafik AN, et al.Role of simvastatin and insulin in memory protection in a rat model of diabetes mellitus and dementia[J]. Brain Res Bull, 2019, 144: 21-27.
[30] Marissal-Arvy N, Campas Marie-Neige, Semont A, et al.Insulin treatment partially prevents cognitive and hippocampal alterations as well as glucocorticoid dysregulation in early-onset insulin-deficient diabetic rats[J]. Psychoneuroendocrinology, 2018, 93: 72-81.
[31] Serhan A, Aerts JL, Boddeke EWGM, et al.Neuroprotection by Insulin-like Growth Factor-1 in Rats with Ischemic Stroke is Associated with Microglial Changes and a Reduction in Neuroinflammation[J]. Neuroscience, 2020, 426: 101-114.
[32] Staszewski J, Brodacki B, Kotowicz J, et al.Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia[J]. J Stroke Cerebrovasc Dis, 2011, 20(2): 150-154.
[33] Zhu C, Chen J, Pan J, et al.Therapeutic effect of intensive glycemic control therapy in patients with traumatic brain injury: A systematic review and meta-analysis of randomized controlled trials[J]. Medicine (Baltimore), 2018, 97(30): e11671.
[34] Rosso C, Corvol JC, Pires C, et al.Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial[J]. Stroke, 2012, 43(9): 2343-2349.
[35] McCormick M, Hadley D, McLean JR,et al. Randomized, controlled trial of insulin for acute poststroke hyperglycemia[J]. Ann Neurol, 2010, 67(5): 570-578.
[36] Lee YY, Lin YM, Leu WJ,et al.Sliding-scale insulin used for blood glucose control: a meta-analysis of randomized controlled trials[J]. Metabolism, 2015, 64(9): 1183-1192.
[37] Larsson M, Patrone C, von Euler M, et al. GLP-1 secretion in acute ischemic stroke: association with functional outcome and comparison with healthy individuals[J]. Cardiovasc Diabetol, 2019, 18(1): 91.
[38] Basalay MV, Davidson SM, Yellon DM, et al.Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues-Liraglutide and Semaglutide[J]. Cardiovasc Drugs Ther, 2019, 33(6): 661-667.
[39] Filchenko I, Simanenkova A, Chefu S, et al.Neuroprotective effect of glucagon-like peptide-1 receptor agonist is independent of glycaemia normalization in type two diabetic rats[J]. Diab Vasc Dis Res, 2018, 15(6): 567-570.
[40] Kuroki T, Tanaka R, Shimada Y,et al.Exendin-4 Inhibits Matrix Metalloproteinase-9 Activation and Reduces Infarct Growth After Focal Cerebral Ischemia in Hyperglycemic Mice[J]. Stroke, 2016, 47(5): 1328-1335.
[41] Zhang G, Kim S, Gu X, et al.DPP-4 Inhibitor Linagliptin is Neuroprotective in Hyperglycemic Mice with Stroke via the AKT/mTOR Pathway and Anti-apoptotic Effects[J]. Neurosci Bull, 2020, 36(4): 407-418.
[42] Chen L, Cao J, Cao D,et al.Protective effect of dexmedetomidine against diabetic hyperglycemia- exacerbated cerebralischemia/reperfusion injury: An in vivo and in vitro study[J]. Life Sci, 2019, 235: 116553.
[43] Huang HK, Yeh JI.Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis[J]. Diabetes Res Clin Pract, 2019, 152: 103-110.
[44] Huang K, Hu Y, Wu Y, et al.Exploratory analysis of oral glibenclamide in acute ischemic stroke[J]. Acta Neurol Scand, 2019, 140(3): 212-218.
[45] Inzucchi SE, Viscoli CM, Young LH,et al.Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease[J]. Diabetes Care, 2016, 9(10): 1684-1692.

糖代谢紊乱与脑卒中的关系研究进展

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	胡素娟, 孙慧, 徐丽芳, 李灵玲, 周搏, 郭晓玲. 阿加曲班与纤溶酶治疗急性缺血性脑卒中的安全性和有效性对比[J]. 承德医学院学报, 2023, 40(2): 104-108.
[2]	孙彩杰, 占婷婷, 王丽丽, 王燕. 基于Logistic回归构建脑卒中后吞咽障碍的预测模型[J]. 承德医学院学报, 2022, 39(6): 494-498.
[3]	周媛, 叶斌, 孙静, 宫鑫. PAI-1基因多态性与缺血性脑卒中rt-PA静脉溶栓后出血性转化和血管再闭塞的相关性[J]. 承德医学院学报, 2022, 39(2): 106-110.
[4]	王霄楠. 多学科合作结合一体化系统管理模式在围手术期住院患者血糖管理中的应用[J]. 承德医学院学报, 2022, 39(2): 117-121.
[5]	胡雪松, 谢保容, 陈建梅. 舌三针联合咽部冰刺激对脑卒中后吞咽障碍患者康复的影响[J]. 承德医学院学报, 2021, 38(6): 485-490.
[6]	雍海荣. 联合引流方式在出血性脑卒中患者中的应用[J]. 承德医学院学报, 2021, 38(6): 508-510.
[7]	张晓萌, 张延红. 脑卒中吞咽障碍患者延续性护理需求的研究现状[J]. 承德医学院学报, 2021, 38(5): 430-434.
[8]	张晓萌, 朱亚芹, 张延红, 周岩. 影响脑卒中吞咽障碍患者预后因素的Meta分析[J]. 承德医学院学报, 2021, 38(4): 281-287.
[9]	李雪峰, 王清芳, 冯玉凤. Lp-PLA2、Annexin A2与溶栓后急性缺血性脑卒中患者预后的相关性[J]. 承德医学院学报, 2021, 38(4): 301-305.
[10]	于静, 吴晓光. 自噬与炎症反应对缺血性脑卒中影响的研究进展[J]. 承德医学院学报, 2021, 38(3): 239-242.
[11]	王雪利, 崔志新, 吕文君, 王妍. 颈动脉斑块的无创影像评价方法的研究进展[J]. 承德医学院学报, 2021, 38(2): 157-161.
[12]	刘梦杰. 缺血性脑卒中相关基因检测的临床意义[J]. 承德医学院学报, 2021, 38(1): 5-8.
[13]	伍文耀, 何清香, 陈秋芳, 李德海. 2型糖尿病患者馒头餐前后血清人神经肽水平的变化[J]. 承德医学院学报, 2021, 38(1): 16-19.
[14]	张晓萌, 张延红, 周岩, 朱亚芹. 脑卒中患者主要照顾者负荷现状及影响因素分析[J]. 承德医学院学报, 2021, 38(1): 37-39.
[15]	孔红梅. 协同护理模式联合悬吊训练在缺血性脑卒中患者中的应用[J]. 承德医学院学报, 2020, 37(6): 498-499.